Global Infectious Immunology Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Infectious Immunology Market Research Report 2024
Infection involves an attack of disease-causing agents such as bacteria and viruses on the host organism’s body that causes disturbances in normal functioning. Immunology is the study of the human body’s resistance to these infections. The combined study of infections and immunology would help authorities to handle infectious disease conditions including HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. The infectious immunology market comprises of the diagnosis and treatment of these infectious diseases with the help of antigen antibody reactions.
According to MRAResearch’s new survey, global Infectious Immunology market is projected to reach US$ 37790 million in 2033, increasing from US$ 22160 million in 2022, with the CAGR of 7.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Infectious Immunology market research.
The global immunology market is gaining momentum due to the availability of various drugs approved by regulatory authorities and trends of improving clinical efficacy for new drug approvals. The high prevalence of immunological disorders further drives the market. The growing number of successful clinical trials due to environmental factors and the demand for biologics leads companies to invest in developing an affordable and effective imitation of biologic drugs and biosimilars. Furthermore, the ever-increasing cases of immunological diseases worldwide due to increasing geriatric populations and the adoption of sedentary lifestyles are pushing the market for growth. Additionally, the rising research and development activities in life sciences and biologics, including immunological drugs, will support market growth. Furthermore, the growing support from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Infectious Immunology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientifics
Bio-Rad Laboratories
Dr. Reddy’s Laboratories
AbbVie Inc
Janssen Global Services
Johnson & Johnson
Amgen Inc
Pfizer Inc
Novartis
Astellas
Bristol-Myers Squibb Company
Merck Sharp & Dohme Corp
UCB SA
Allergan
Segment by Type
Diagnostic Kits
Instruments
Reagents
HIV
TB
HBV and HCV
Pneumonia
Malaria
Inflammatory Bowel Diseases
Auto Immune Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Infectious Immunology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Infectious Immunology market is projected to reach US$ 37790 million in 2033, increasing from US$ 22160 million in 2022, with the CAGR of 7.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Infectious Immunology market research.
The global immunology market is gaining momentum due to the availability of various drugs approved by regulatory authorities and trends of improving clinical efficacy for new drug approvals. The high prevalence of immunological disorders further drives the market. The growing number of successful clinical trials due to environmental factors and the demand for biologics leads companies to invest in developing an affordable and effective imitation of biologic drugs and biosimilars. Furthermore, the ever-increasing cases of immunological diseases worldwide due to increasing geriatric populations and the adoption of sedentary lifestyles are pushing the market for growth. Additionally, the rising research and development activities in life sciences and biologics, including immunological drugs, will support market growth. Furthermore, the growing support from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Infectious Immunology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientifics
Bio-Rad Laboratories
Dr. Reddy’s Laboratories
AbbVie Inc
Janssen Global Services
Johnson & Johnson
Amgen Inc
Pfizer Inc
Novartis
Astellas
Bristol-Myers Squibb Company
Merck Sharp & Dohme Corp
UCB SA
Allergan
Segment by Type
Diagnostic Kits
Instruments
Reagents
Segment by Application
HIV
TB
HBV and HCV
Pneumonia
Malaria
Inflammatory Bowel Diseases
Auto Immune Diseases
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Infectious Immunology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source